Phase IV filgrastim study shows drug lives up to expectations

Article

Amgen's filgrastim delivers what it promises in a phase IV study

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Q&A: Pharmacist Discusses Counseling Considerations for Menstrual Pain

Q&A: Pharmacist Discusses Counseling Considerations for Menstrual Pain

Ashley Gallagher;Joanna Lewis, PharmD, MBA
September 16th 2025
Article
What New ICU Guidelines Mean for the Pharmacist Profession

What New ICU Guidelines Mean for the Pharmacist Profession

Brian Nowosielski;Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP
September 16th 2025
Podcast
Data Show Sustained Improvement in Migraine Symptoms With Eptinezumab

Data Show Sustained Improvement in Migraine Symptoms With Eptinezumab

Ashley Gallagher
September 16th 2025
Article
How Real Patient Experiences Have Helped Bolster Advocacy for PBM Reform

How Real Patient Experiences Have Helped Bolster Advocacy for PBM Reform

Brian Nowosielski
September 16th 2025
Podcast
One in 6 Parents in US Delay or Skip Routine Vaccination for Children

One in 6 Parents in US Delay or Skip Routine Vaccination for Children

Ashley Gallagher
September 16th 2025
Article
Adverse Events Prominent During Post-Pneumococcal Vaccination

Adverse Events Prominent During Post-Pneumococcal Vaccination

Brian Nowosielski
September 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.